„Das Richtige tun (statt Dinge richtig tun)“

• Literaturverzeichnis

• 1 Statistisches Bundesamt (Destatis). 13.10.2021
• 2 Disposable Gloves Market Size, Share & Trends Analysis Report By Product, By Material, By End-use And Segment Forecasts, 2020–2028. [Online] März 2021. ReportLinker. Verfügbar unter (Stand 15.03.2021): https://www.reportlinker.com/p06046007/Disposable-Gloves-Market-Size-Share-Trends-Analysis-Report-By-Product-By-Material-By-End-use-And-Segment-Forecasts.html?utm_source=GNW
• 3 Global Nitrile Gloves Market – Analysis By Outlook Type (Powdered, Powder-Free), Grade (Medical, Industrial), End Users, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026). [Online] Februar 2021. ReportLinker. Verfügbar unter (Stand 15.03.2021): https://www.reportlinker.com/p06030142/Global-Nitrile-Gloves-Market-Analysis-By-Outlook-Type-Powdered-Powder-Free-Grade-Medical-Industrial-End-Users-By-Region-By-Country-Edition-Market-Insights-Covid-19-Impact-Competition-and-Forecast.html
• 4 Kaufmannische Krankenkasse (KKH). [Online] 29. April 2020. Verfügbar unter (Stand 22.09.2021): https://www.kkh.de/presse/pressemeldungen/corona-angst-fuehrt-zu-mehr-disziplin-beim-haendewaschen
• 5 Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen (NRZ). MRSA-KISS. [Online]. Verfügbar unter (Stand 13.10.2021): https://www.nrz-hygiene.de/surveillance/kiss/mrsa-kiss/
• 6 Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2020. [Online] 01. März 2021. Robert-Koch-Institut. Verfügbar unter (Stand 13.10.2021): https://www.rki.de/DE/Content/Infekt/Jahrbuch/Jahrbuch_2020.pdf?__blob=publicationFile
• 7 Schaff E. Drug-resistant infections have increased in hospitals during the pandemic. New York Times Company 2021; 59: 169
• 8 Srinivasan A. Centers for Disease Control and Prevention (CDC). The Intersection of Antibiotic Resistance (AR), Antibiotic Use (AU), and COVID-19. [Online] 09. September 2020. Verfügbar unter (Stand 13.10.21): https://www.hhs.gov/sites/default/files/srinivasan-covid-and-amr-overview.pdf
• 9 Perez S, Innes GK, Spalding Walters M. et al. Centers for Disease Control and Prevention (CDC). Increase in Hospital-Acquired Carbapenem-Resitant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions. [Online] 04. Dezember 2020. Verfügbar unter (Stand 13.10.21): https://www.cdc.gov/mmwr/volumes/69/wr/mm6948e1.htm
• 10 Prestel C, EAnderson E, Forsberg K. et al. Centers für Disease Control and Prevention. Candida auris Outbreak in a COVID-19 Specialty Care Unit. [Online] 08. Januar 2021. Verfügbar unter (Stand 13.10.21): https://www.cdc.gov/mmwr/volumes/70/wr/mm7002e3.htm
• 11 CDC & AR experts discuss addressing AR after COVID-19. [Online] Juli 2021. Centers for Disease Control and Prevention. Verfügbar unter (Stand 13.10.21): https://www.cdc.gov/drugresistance/solutions-initiative/stories/experts-discuss-AR-post-pandemic.html
• 12 Lo SH, Lin CY, Hung CT. et al. The impact of universal face masking and enhanced hand hygiene for COVID-19 disease prevention on the incidence of hospital-acquired infections in a Taiwanese hospital. International Journal of Infectious Diseases 2021; 104: 15-18
• 13 Bentivegna E, Luciani M, Arcari L. et al. Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective Study. International Journal of Enviromental Research and Public Health 2021; 18: 1003
• 14 Chamieh A, Zgheib R, El-Sawalhi S. et al. Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015-2020: COVID-19 Aftermath. Antibiotics 2021.
• 15 Belvisi V, Del Borgo C, Vita S. et al. IPC Program Working Group. Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action? . Journal of Hospital Infection 2021; 109: 29-31
• 16 Ponce-Alonso M, de la Fuente JS, Rincon-Carlavilla A. et al. Impact of the coronavirus disease 2019 (COVID-19) pandemic on nosocomial Clostridioides difficile infection. Infection Control & Hospital Epidemiology 2020; 42: 406-410
• 17 Hawes AM, Desai A, Patel PK. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?. Anerobe 2021; 70: 102384
• 18 Tomczyk S, Taylor A, Brown A. et al. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey. Journal of Antimicrobial Chemotherapy 2021; 76: 3045-3058